Category: Biotech, Biotechnology

The intersection of artificial intelligence and biotechnology presents unprecedented opportunities for advancing drug discovery and development. Leen Kawas, Managing General Partner at Propel Bio Partners, has identified several critical ethical challenges that will define the next decade of AI implementation in the biotechnology sector. “AI enables us to bring a number of different data together…